A nurse is reviewing the laboratory values of a client who is taking atorvastatin. Which of the following laboratory values indicates the treatment has been effective?
BUN 15 mg/dl.
LDL 120 mg/dL
Urine specific gravity 1.020
Blood glucose 90 mg/dl
The Correct Answer is B
A. BUN 15 mg/dL:
Incorrect Explanation: Blood urea nitrogen (BUN) is not a specific marker for assessing the effectiveness of atorvastatin treatment.
Explanation: BUN is a measure of kidney function and the breakdown of protein in the body. It is not directly related to the cholesterol-lowering effects of atorvastatin.
B. LDL 120 mg/dL.
Explanation:
Atorvastatin is a medication used to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, which is often referred to as "bad" cholesterol. Elevated LDL cholesterol levels are a risk factor for cardiovascular disease. The goal of using medications like atorvastatin is to reduce LDL cholesterol levels to a target range, as recommended by healthcare guidelines.
A lower LDL cholesterol level indicates that the treatment with atorvastatin has been effective in achieving the desired therapeutic goal of lowering cholesterol levels and reducing the risk of cardiovascular events. Therefore, a decrease in LDL cholesterol is a positive outcome of atorvastatin therapy.
C. Urine specific gravity 1.020:
Incorrect Explanation: Urine-specific gravity is not a marker for assessing the effectiveness of atorvastatin.
Explanation: Urine-specific gravity measures the concentration of urine and is related to hydration status and kidney function. It is not used to evaluate the effectiveness of cholesterol-lowering medications like atorvastatin.
D. Blood glucose 90 mg/dL:
Incorrect Explanation: A blood glucose level of 90 mg/dL is not indicative of the effectiveness of atorvastatin treatment.
Explanation: Blood glucose level measures the amount of sugar in the bloodstream and is unrelated to the cholesterol-lowering effects of atorvastatin.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Place the medications on the back of the client's tongue:
Incorrect Explanation: Placing medications on the back of the tongue can increase the risk of choking and aspiration, especially in individuals with dysphagia.
Explanation: Individuals with dysphagia have difficulty swallowing and are at an increased risk of choking or aspirating (inhaling) substances into the lungs. Placing medications on the back of the tongue can be unsafe and is not recommended.
B. Tilt the client's head back when administering the medications:
Incorrect Explanation: Tipping the head back can worsen swallowing difficulties and increase the risk of choking or aspiration.
Explanation: Tipping the head back can compromise the natural swallowing mechanism and increase the risk of aspiration. It's important to keep the client's head in an upright position to aid safe swallowing.
C. Administer more than one pill to the client at a time:
Incorrect Explanation: Administering multiple pills at once can increase the risk of choking and aspiration, especially in individuals with dysphagia.
Explanation: Administering multiple pills at once can overwhelm the client's ability to swallow safely. This action can increase the risk of choking and aspiration, which is especially dangerous for individuals with dysphagia.
D. Mix the medications with a semisolid food for the client:
Correct Answer: This action is appropriate and safer for administering medications to an older adult client with dysphagia.
Explanation: Mixing medications with semisolid food, such as applesauce or yogurt, can help the client swallow more easily and reduce the risk of choking or aspiration. It's important to check with the healthcare provider or pharmacist to ensure that the medications can be mixed with food and that there are no interactions.
Correct Answer is D
Explanation
A. Administer the medication into the client's muscles.
Explanation: This is incorrect because enoxaparin is usually administered subcutaneously, not into the muscle.
B. Apply firm pressure to the injection site following administration.
Explanation: This is incorrect because while applying gentle pressure after a subcutaneous injection is common practice, it is not specific to enoxaparin.
C. Insert the syringe needle halfway into the client's skin.
Explanation: This is incorrect because the needle should be inserted fully into the subcutaneous tissue, not just halfway, for proper administration of enoxaparin.
D. Expel the air bubble from the syringe prior to injection.
Explanation: This is the correct action. Expelling air bubbles from the syringe prior to injection helps ensure accurate dosing and prevents air from being injected into the subcutaneous tissue.
When administering enoxaparin (low molecular weight heparin) subcutaneously, it's important to expel any air bubbles from the syringe before injection. Air bubbles can cause discomfort and inaccuracies in dosage. The nurse should gently tap the syringe to move air bubbles to the top and then push the plunger slightly to expel the air. The other options are not correct procedures for administering enoxaparin. It is typically injected into the subcutaneous tissue, not a muscle, and firm pressure is not typically applied after administration. The needle is fully inserted into the skin, not halfway.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.